This funding opportunity aims to extensively research Monkeypox and other significant zoonotic and vaccine-preventable diseases in the Democratic Republic of the Congo (DRC), focusing on a study site in Tshuapa Province. The grant supports investigations into the epidemiological, ecological, and anthropological factors of these diseases, alongside assessing clinical intervention strategies. Key activities include enhancing laboratory surveillance, exploring viral reservoirs and the human-animal interface, conducting epidemiologic studies, and performing genomic analysis. The research also covers risk mitigation, improving health communication, and evaluating clinical vaccines and therapies. Ultimately, this initiative seeks to equip the DRC Ministry of Health and other stakeholders with crucial evidence-based insights to develop effective public health interventions and strategies.
Opportunity ID: 337529
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CK-22-001 |
| Funding Opportunity Title: | Investigation of Monkeypox and Other Zoonotic Diseases in the Democratic Republic of the Congo (DRC) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.084 — Prevention of Disease, Disability, and Death by Infectious Diseases |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jan 24, 2022 |
| Last Updated Date: | Jan 24, 2022 |
| Original Closing Date for Applications: | Apr 01, 2022 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
| Current Closing Date for Applications: | Feb 28, 2022 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
| Archive Date: | Jun 01, 2022 |
| Estimated Total Program Funding: | $3,500,000 |
| Award Ceiling: | $700,000 |
| Award Floor: | $600,000 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | The Kinshasa School of Public Health (KSPH) is the only eligible applicant. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The purpose of this notice of funding opportunity (NOFO) is to investigate the epidemiological, ecological, and anthropological aspects of monkeypox and assess clinical intervention strategies in the Democratic Republic of the Congo (DRC), including one study site in Tshuapa Province. This research may also extend to other zoonotic and vaccine-preventable diseases that are of importance in the DRC. Research activities should focus on improvement and evaluation of laboratory-based surveillance systems, investigations of viral reservoirs and the human-animal interface, epidemiologic investigations, genome sequencing and phylogenetic analysis, risk mitigation, enhancing health communication strategies, and clinical evaluation of vaccines and therapeutic treatments. The research supported by this NOFO should provide the DRC Ministry of Health and other key stakeholders with evidence-based strategies to develop important interventions and public health strategies. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Amy Yang
vdz9@cdc.gov Email:vdz9@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Update NOFO template. | Jan 24, 2022 | |
| Jan 24, 2022 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CK-22-001 |
| Funding Opportunity Title: | Investigation of Monkeypox and Other Zoonotic Diseases in the Democratic Republic of the Congo (DRC) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.084 — Prevention of Disease, Disability, and Death by Infectious Diseases |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jan 24, 2022 |
| Last Updated Date: | Jan 24, 2022 |
| Original Closing Date for Applications: | Apr 01, 2022 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
| Current Closing Date for Applications: | Feb 28, 2022 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
| Archive Date: | Jun 01, 2022 |
| Estimated Total Program Funding: | $3,500,000 |
| Award Ceiling: | $700,000 |
| Award Floor: | $600,000 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | The Kinshasa School of Public Health (KSPH) is the only eligible applicant. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The purpose of this notice of funding opportunity (NOFO) is to investigate the epidemiological, ecological, and anthropological aspects of monkeypox and assess clinical intervention strategies in the Democratic Republic of the Congo (DRC), including one study site in Tshuapa Province. This research may also extend to other zoonotic and vaccine-preventable diseases that are of importance in the DRC. Research activities should focus on improvement and evaluation of laboratory-based surveillance systems, investigations of viral reservoirs and the human-animal interface, epidemiologic investigations, genome sequencing and phylogenetic analysis, risk mitigation, enhancing health communication strategies, and clinical evaluation of vaccines and therapeutic treatments. The research supported by this NOFO should provide the DRC Ministry of Health and other key stakeholders with evidence-based strategies to develop important interventions and public health strategies. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Amy Yang
vdz9@cdc.gov Email:vdz9@cdc.gov |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CK-22-001 |
| Funding Opportunity Title: | Investigation of Monkeypox and Other Zoonotic Diseases in the Democratic Republic of the Congo (DRC) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.084 — Prevention of Disease, Disability, and Death by Infectious Diseases |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 24, 2022 |
| Last Updated Date: | Jan 24, 2022 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Apr 01, 2022 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
| Archive Date: | Jun 01, 2022 |
| Estimated Total Program Funding: | $3,500,000 |
| Award Ceiling: | $700,000 |
| Award Floor: | $600,000 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | The Kinshasa School of Public Health (KSPH) is the only eligible applicant. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The purpose of this notice of funding opportunity (NOFO) is to investigate the epidemiological, ecological, and anthropological aspects of monkeypox and assess clinical intervention strategies in the Democratic Republic of the Congo (DRC), including one study site in Tshuapa Province. This research may also extend to other zoonotic and vaccine-preventable diseases that are of importance in the DRC. Research activities should focus on improvement and evaluation of laboratory-based surveillance systems, investigations of viral reservoirs and the human-animal interface, epidemiologic investigations, genome sequencing and phylogenetic analysis, risk mitigation, enhancing health communication strategies, and clinical evaluation of vaccines and therapeutic treatments. The research supported by this NOFO should provide the DRC Ministry of Health and other key stakeholders with evidence-based strategies to develop important interventions and public health strategies. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Amy Yang
vdz9@cdc.gov Email:vdz9@cdc.gov |
Related Documents
Folder 337529 Full Announcement-Full Announcement -> Foa_Content_of_RFA-CK-22-001 FORMS F.pdf
Packages
| Agency Contact Information: | Amy Yang vdz9@cdc.gov Email: vdz9@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.084 | RFA-CK-22-001 | Investigation of Monkeypox and Other Zoonotic Diseases in the Democratic Republic of the Congo (DRC) | PKG00271519 | Jan 24, 2022 | Feb 28, 2022 | View |
Package 1
Mandatory forms
337529 RR_SF424_2_0-2.0.pdf
337529 PHS398_CoverPageSupplement_5_0-5.0.pdf
337529 RR_OtherProjectInfo_1_4-1.4.pdf
337529 RR_Budget_1_4-1.4.pdf
337529 PHS398_ResearchPlan_4_0-4.0.pdf
337529 PerformanceSite_2_0-2.0.pdf
337529 RR_KeyPersonExpanded_2_0-2.0.pdf
337529 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
337529 RR_SubawardBudget30_1_4-1.4.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
